Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells
about
Invariant NKT cells as novel targets for immunotherapy in solid tumorsFunctional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cellsCD161+ T (NT) cells exist predominantly in human intestinal epithelium as well as in liverHeterogeneity in phenotype and function of CD8+ and CD4/CD8 double-negative Natural Killer T cell subsets in sooty mangabeysDevelopment of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7CD1d and invariant NKT cells at the human maternal-fetal interface.Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potencySelective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.Peripheral blood invariant natural killer T cells throughout pregnancy and in preeclamptic women.Invariant NKT cells: regulation and function during viral infection.CD8+CD28- T cells: certainties and uncertainties of a prevalent human T-cell subset.Ligand-independent assembly of recombinant human CD1 by using oxidative refolding chromatographyRapid development of a gamma interferon-secreting glycolipid/CD1d-specific Valpha14+ NK1.1- T-cell subset after bacterial infection.Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment.Against the self: dendritic cells versus cancer.Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanismDeficiency of invariant natural killer T cells in coeliac diseaseNatural killer T cell-mediated antitumor immune responses and their clinical applications.Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells.Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies.Potential Therapeutic Use of PPARgamma-Programed Human Monocyte-Derived Dendritic Cells in Cancer Vaccination Therapy.Altered effector function of peripheral cytotoxic cells in COPD.Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders.Intracellular bacterial infection and invariant NKT cells.Human invariant natural killer T cells: implications for immunotherapy.Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapy.CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection.Potentiation of murine innate immunity by alpha-galacturonosyl-type glycosphingolipids isolated from Sphingomonas yanoikuyae and S. terrae.Ligation of CD44 leads to killing activity in human peripheral mononuclear cells via MAP kinase and tyrosine kinases.Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells.Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to V alpha 24+ NKT cell-mediated cytotoxicity.Differential pulmonic NK and NKT cell responses in Schistosoma japonicum-infected mice.Generation of Valpha14 NKT cells in vitro from hematopoietic precursors residing in bone marrow and peripheral blood.Regulation of the induction and function of cytotoxic T lymphocytes by natural killer T cell.In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.CD1d-dependent, iNKT-cell cytotoxicity against keratinocytes in allergic contact dermatitis.Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets.Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells.
P2860
Q21284987-FA19DAFB-D506-458B-82E5-B6B05026C922Q24645351-C9062B3A-CF5B-4CA9-ABA6-90E118AE11CDQ24681146-49DA25F2-9F07-4A5C-A5E4-E94DD1B9D20EQ29396370-1FF06D9F-0CAF-4E34-8819-3671EE6C4F37Q33782527-B8838699-B84C-4182-9635-3B9F3495E7E8Q34160929-8DADBD31-C71B-4150-AD3A-795CDEF5FE73Q34321127-6F855022-DA79-48C2-A488-E5CFAC5B2C22Q34338958-CFB18860-0823-4680-A4FA-6ACBE2A28F4CQ34342894-EEA4A7DD-E2BA-4474-8E06-805B01FC0BFCQ34368884-59D4D3F2-6E37-4A6A-8B00-A48BB713523DQ34390484-BDE85602-58C2-4591-8AA6-AED26506B91AQ34546418-04642B44-7EB6-4A86-A6D5-9DF2F4B6EDB2Q34722422-E502D1F5-8068-4639-AD03-B546E1914449Q35073920-4F118309-35B1-4638-8E06-01845893B8A4Q35096435-7AC0DC43-5C6B-4B4D-B893-9B7B0B44C379Q35219334-43C55C29-DC76-4C73-90F7-3A2C6FBBCDF8Q35866143-267599C5-75ED-4F9C-B731-53A7A0A3424EQ35953847-A5F93405-7BAA-49DF-9373-5874DD6E7A81Q36521991-F8E47687-50E5-4BFE-AE70-B98879A08380Q36570136-1E601E1B-515B-4FA0-850D-CD962C988ED3Q36695207-6CD7DDE2-7C1D-46D7-8745-30AE88AA8F3DQ36969083-09F6EAC2-A5FA-4612-8061-1DDD4C15054CQ37250873-76EAD76D-1B46-49BB-A9AD-D081E144B2A5Q37381691-5E19E077-D17A-47FB-B3FC-88A85DB435D3Q37405955-3C1F6013-3887-4A7D-AE2A-0F722B472532Q37565143-3A2CBEBB-C4D0-453A-A494-ADBB2D20F6D8Q38666579-84C07052-69D9-4C53-8673-4CF53EE789B3Q39006369-585A116A-7FD5-406E-A4D5-CC7EC7958450Q39833305-FB98E736-3F39-44CC-B117-D784D3D36050Q39939249-869F4258-6A77-469B-BA42-B6C189C67FCCQ40169102-6850AAB6-B740-471B-9419-47CA64980B70Q40214554-EE96B43D-D227-4C5E-A0E8-64401DC66B62Q40286194-0F9DACD7-CB00-4CA3-81FB-427F402ED4B7Q40428450-CEE22F1B-EA84-4866-B732-48115A47ABA7Q40584265-5445BED9-8AF9-47AB-8CD3-650F3A719BD3Q40659279-D0DB3708-997B-4D5B-927F-69649027281DQ42256307-2AB1266C-EF91-4A08-953B-115E7D5F8A00Q42714148-9650D33F-1241-4177-9954-A66F203CC4D9Q44326392-F7BA8A96-E189-43F5-A024-9EEC3BC64009Q44452165-1F4F7E68-D209-4EBD-B381-B020CAC1C78D
P2860
Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@ast
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@en
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@en-gb
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@nl
type
label
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@ast
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@en
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@en-gb
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@nl
prefLabel
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@ast
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@en
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@en-gb
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@nl
P2093
P1476
Analysis of human V alpha 24+ ...... nocyte-derived dendritic cells
@en
P2093
K Tadokoro
S A Porcelli
T Takahashi
Y Ishikawa
P304
P356
10.4049/JIMMUNOL.164.9.4458
P407
P577
2000-05-01T00:00:00Z